Active RFAs at NIH (March 10, 2021)
| Title | Expiry_Date | Activity_Code | RFA_Number | URL | Org |
| Data Standards for Tobacco Research and Scientific Review Program (U24) Clinical Trial Not Allowed | 6/2/2021 | U24 | RFA-FD-22-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-22-002.html | FDA |
| Fogarty Global Trauma and Injury Research Training Program (D43 Clinical Trial Optional) | 4/17/2021 | D43 | RFA-TW-21-003 | https://grants.nih.gov/grants/guide/rfa-files/RFA-TW-21-003.html | FIC |
| Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional) | 7/31/2021 | R01 | RFA-CA-20-027 | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-027.html | NCI |
| Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional) | 7/31/2021 | R21 | RFA-CA-20-028 | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-028.html | NCI |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | 9/29/2021 | R33 | RFA-CA-21-004 | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-004.html | NCI |
| BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) | 10/28/2023 | R21 | RFA-EY-21-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-EY-21-001.html | NEI |
| Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed) | 6/16/2021 | R01 | RFA-AG-22-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-002.html | NIA |
| The Cellular Scale Connectome in Aging and Alzheimers Disease (U01 Clinical Trial Not Allowed) | 6/16/2021 | U01 | RFA-AG-22-008 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-008.html | NIA |
| New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed) | 6/18/2021 | R01 | RFA-AG-22-006 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-006.html | NIA |
| Early-Phase Clinical Trials of Novel Interventions to Prevent, Delay, or Treat Aging-Related Conditions by Targeting Aging-Related Mechanisms (U01 Clinical Trial Required) | 6/18/2021 | U01 | RFA-AG-22-011 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-011.html | NIA |
| Triadic Interactions in Clinical Encounters Involving People with Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD), Clinicians, and Care Partners (R01 Clinical Trial Optional) | 6/24/2021 | R01 | RFA-AG-22-020 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-020.html | NIA |
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) | 10/22/2022 | K76 | RFA-AG-21-021 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-021.html | NIA |
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) | 10/22/2022 | K76 | RFA-AG-21-020 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-020.html | NIA |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) | 4/15/2021 | R21 | RFA-AA-21-004 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-21-004.html | NIAAA |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) | 4/15/2021 | R01 | RFA-AA-21-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-21-002.html | NIAAA |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) | 4/15/2021 | R03 | RFA-AA-21-003 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-21-003.html | NIAAA |
| Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional) | 5/27/2021 | U01 | RFA-AA-20-013 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-20-013.html | NIAAA |
| Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24) (Clinical Trial Optional) | 5/27/2021 | U24 | RFA-AA-20-012 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-20-012.html | NIAAA |
| Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional) | 5/27/2021 | U24 | RFA-AA-20-011 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-20-011.html | NIAAA |
| NIAMS Centers of Research Translation (CORT) (P50 - Clinical Trial Not Allowed) | 5/12/2021 | P50 | RFA-AR-22-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-22-001.html | NIAMS |
| BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01 Clinical Trial not allowed) | 9/4/2021 | U01 | RFA-EB-19-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-19-002.html | NIBIB |
| BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trial Not Allowed) | 9/4/2021 | R01 | RFA-EB-20-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-20-001.html | NIBIB |
| BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) | 9/15/2021 | R01 | RFA-EB-20-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-20-002.html | NIBIB |
| Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed) | 7/21/2021 | U01 | RFA-DA-21-019 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-21-019.html | NIDA |
| Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional) | 8/14/2021 | R61/R33 | RFA-DA-21-005 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-21-005.html | NIDA |
| HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 - Clinical Trial Optional) | 9/9/2021 | R41/R42 | RFA-DA-19-020 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-020.html | NIDA |
| HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional) | 9/9/2021 | R43/R44 | RFA-DA-19-019 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-019.html | NIDA |
| NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed) | 9/16/2021 | R21 | RFA-DA-22-008 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-008.html | NIDA |
| High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed) | 9/16/2021 | R01 | RFA-DA-22-006 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-006.html | NIDA |
| Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) | 7/15/2022 | R61/R33 | RFA-DA-22-004 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-004.html | NIDA |
| BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 - Clinical Trial Not Allowed) | 10/15/2022 | U01 | RFA-DA-21-006 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-21-006.html | NIDA |
| Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) | 10/26/2022 | R01 | RFA-DA-22-010 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-010.html | NIDA |
| NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional) | 6/5/2021 | R21/R33 | RFA-DC-19-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-19-001.html | NIDCD |
| Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed) | 6/14/2023 | R25 | RFA-DC-20-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-20-002.html | NIDCD |
| NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) | 7/27/2021 | R35 | RFA-DE-22-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DE-22-001.html | NIDCR |
| Diabetes Research Centers (P30 Clinical Trial Optional) | 5/21/2021 | P30 | RFA-DK-20-025 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-025.html | NIDDK |
| Immune Cell Engineering For Targeted Therapy And Disease Monitoring in Type 1 Diabetes (R01 Clinical Trial Not Allowed) | 6/23/2021 | R01 | RFA-DK-21-005 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-005.html | NIDDK |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) | 7/2/2021 | P30 | RFA-DK-19-004 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-004.html | NIDDK |
| Small Research Grants for Analyses of Down Syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed) | 11/4/2021 | R03 | RFA-OD-20-006 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-006.html | NIH |
| Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) | 11/4/2021 | R01 | RFA-OD-20-005 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-005.html | NIH |
| Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) | 11/4/2021 | R61/R33 | RFA-OD-20-003 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-003.html | NIH |
| INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) | 11/4/2021 | R21 | RFA-OD-20-004 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-004.html | NIH |
| Tobacco Regulatory Science (R01 Clinical Trial Optional) | 2/15/2023 | R01 | RFA-OD-21-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-21-002.html | NIH |
| Limited Competition to Convert the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Study Cohort to a Research Resource (R24 - Clinical Trial Not Allowed) | 5/11/2021 | R24 | RFA-MH-21-170 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-170.html | NIMH |
| BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) | 5/28/2021 | UG3/UH3 | RFA-MH-19-135 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-135.html | NIMH |
| BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed) | 5/28/2021 | R01 | RFA-MH-20-135 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-135.html | NIMH |
| Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) | 6/11/2021 | R21 | RFA-MH-20-351 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-351.html | NIMH |
| Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) | 6/11/2021 | R01 | RFA-MH-20-350 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-350.html | NIMH |
| Post-Acute Interventions for the Treatment of Anorexia Nervosa (R34 Clinical Trial Required) | 6/16/2021 | R34 | RFA-MH-20-500 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-500.html | NIMH |
| Practice-Based Research for Implementing Scalable Evidence-Based Prevention Interventions in Primary Care Settings (R01 Clinical Trial Optional) | 7/2/2021 | R01 | RFA-MH-20-505 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-505.html | NIMH |
| Practice-Based Research for Implementing Scalable Evidence-Based Prevention Interventions in Primary Care Settings (R34 Clinical Trial Required) | 7/2/2021 | R34 | RFA-MH-20-506 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-506.html | NIMH |
| BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) | 9/3/2021 | R01 | RFA-MH-20-128 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-128.html | NIMH |
| NIMH Instrumentation Program (S10 Clinical Trial Not Allowed) | 10/9/2021 | S10 | RFA-MH-20-555 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-555.html | NIMH |
| BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed) | 10/20/2021 | U01 | RFA-MH-20-556 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-556.html | NIMH |
| Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional) | 11/16/2021 | R01 | RFA-MH-21-120 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-120.html | NIMH |
| Laboratories to Optimize Digital Health (R01 Clinical Trial Required) | 3/2/2022 | R01 | RFA-MH-20-510 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-510.html | NIMH |
| BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed) | 3/11/2022 | R01 | RFA-MH-21-140 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-140.html | NIMH |
| Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) | 6/16/2022 | R43/R44 | RFA-MH-21-112 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-112.html | NIMH |
| Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) | 6/16/2022 | R34 | RFA-MH-21-111 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-111.html | NIMH |
| Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) | 6/16/2022 | R01 | RFA-MH-21-110 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-110.html | NIMH |
| NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) | 6/21/2022 | R01 | RFA-MH-20-525 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-525.html | NIMH |
| BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) | 12/10/2022 | F32 | RFA-MH-20-620 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-620.html | NIMH |
| BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) | 7/15/2023 | R24 | RFA-MH-20-600 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-600.html | NIMH |
| NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00) | 4/16/2021 | F99/K00 | RFA-NS-19-011 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-011.html | NINDS |
| BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01-Clinical Trials Not Allowed) | 5/5/2021 | U01 | RFA-NS-18-019 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-019.html | NINDS |
| BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trials Not Allowed) | 5/5/2021 | R01 | RFA-NS-18-020 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-020.html | NINDS |
| BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional) | 6/16/2021 | U01 | RFA-NS-20-029 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-029.html | NINDS |
| BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) | 6/28/2021 | U24 | RFA-NS-19-006 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-006.html | NINDS |
| BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed) | 10/30/2021 | U19 | RFA-NS-19-003 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-003.html | NINDS |
| BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required) | 10/30/2021 | U01 | RFA-NS-19-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-001.html | NINDS |
| BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 - Clinical Trials Not Allowed) | 11/10/2021 | R34 | RFA-NS-18-014 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-014.html | NINDS |
| HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) | 9/8/2022 | UG3/UH3 | RFA-NS-21-010 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-010.html | NINDS |
| HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) | 9/9/2022 | R41/R42 | RFA-NS-20-009 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-009.html | NINDS |
| HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) | 9/9/2022 | R43/R44 | RFA-NS-20-010 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-010.html | NINDS |
| HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) | 9/9/2022 | R41/R42 | RFA-NS-20-008 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-008.html | NINDS |
| HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) | 9/9/2022 | R43/R44 | RFA-NS-20-011 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-011.html | NINDS |
| NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional) | 9/27/2022 | P50 | RFA-NS-21-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-001.html | NINDS |
| BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) | 10/4/2022 | R01 | RFA-NS-20-006 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-006.html | NINDS |
| BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) | 11/12/2022 | K99/R00 | RFA-NS-19-043 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-043.html | NINDS |
| BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) | 11/12/2022 | K99/R00 | RFA-NS-19-044 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-044.html | NINDS |
| Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required) | 7/11/2022 | K01 | RFA-OD-20-011 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-011.html | ODP |
| Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required) | 7/11/2022 | K99/R00 | RFA-OD-20-010 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-010.html | ODP |
| Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed) | 7/11/2022 | K99/R00 | RFA-OD-20-009 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-009.html | ODP |
| Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed) | 7/11/2022 | K01 | RFA-OD-20-008 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-008.html | ODP |
| Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) | 9/9/2022 | R24 | RFA-OD-19-027 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-027.html | ORIP |
| Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) | 1/8/2023 | P40 | RFA-OD-20-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-002.html | ORIP |
| The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) | 11/27/2021 | R01 | RFA-OD-19-029 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-029.html | ORWH |
| NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed) | 4/24/2021 | U24 | RFA-RM-20-023 | https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-20-023.html | RMOD |
| NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed) | 4/24/2021 | U24 | RFA-RM-21-019 | https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-21-019.html | RMOD |
Simons Foundation Autism Research Initiative (SFARI)
SFARI Explorer Awards: This award program is designed to enhance our existing support of autism research by providing timely resources to enable focused experiments highly relevant to our mission. A deeper understanding of the mechanisms underlying autism spectrum disorders or potential therapeutic approaches will require investigation at multiple levels, including but not limited to studies focused on gene discovery, molecular mechanisms, circuits, anatomy, and cognition and behavior. We will consider proposals at all of these levels.
The maximum budget is $70,000, including indirect costs for one (1) year, non-renewable.
Explorer Awards are intended to provide resources to support exploratory experiments that will strengthen hypotheses and lead to the formulation of competitive applications for subsequent larger-scale funding by SFARI or other organizations. Innovative, high-risk/high-impact proposals are encouraged. We especially encourage applications from investigators who are new to the field of autism, but who have expertise that could be brought to bear on this complex disorder.
Applications are considered on a rolling basis, with a response time as early as 30 days.